Filing Details
- Accession Number:
- 0001061983-21-000240
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-20 18:56:02
- Reporting Period:
- 2021-10-19
- Accepted Time:
- 2021-10-20 18:56:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1073385 | Lynne B Parshall | 280 East Grand Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-19 | 1,999 | $6.84 | 6,999 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-10-19 | 1,999 | $35.73 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-10-19 | 8,333 | $6.60 | 13,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-10-19 | 8,333 | $35.73 | 5,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-10-19 | 8,333 | $0.00 | 8,333 | $6.60 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-10-19 | 1,999 | $0.00 | 1,999 | $6.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-03-07 | 2023-02-07 | No | 4 | M | Direct |
| 2,798 | 2013-05-01 | 2023-04-01 | No | 4 | M | Direct |
Footnotes
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021.
Billionaire Hedge Funds
